Document is current
Any future updates will be listed below
-
Authors
Martin-Herranz, Daniel E. http://orcid.org/0000-0002-2285-3317
Aref-Eshghi, Erfan
Bonder, Marc Jan
Stubbs, Thomas M.
Choufani, Sanaa
Weksberg, Rosanna
Stegle, Oliver
Sadikovic, Bekim
Reik, Wolf
Thornton, Janet M.
-
Funding
Funding for this research was provided by:
European Molecular Biology Laboratory (Predoctoral fellowship (40579), EMBL Interdisciplinary Postdoc (EI3POD) program under Marie Skłodowska-Curie Actions COFUND (664726))
- License Information
-
More Information
Article History
Received: 8 February 2019
Accepted: 3 July 2019
First Online: 14 August 2019
Ethics approval and consent to participate
: The study protocol has been approved by the Western University Research Ethics Board (REB ID 106302) and McMaster University and the Hamilton Integrated Research Ethics Boards (REB ID 13-653-T). All of the participants provided informed consent prior to sample collection. All of the samples and records were de-identified before any experimental or analytical procedures. The research was conducted in accordance with all relevant ethical regulations. All experimental methods comply with the Helsinki Declaration.
: Not applicable.
: DEMH and TMS are founders and shareholders of Chronomics Limited, a UK-based company that provides epigenetic testing. WR is a consultant and shareholder of Cambridge Epigenetix. All other authors declare that they have no competing interests.
